Thierry Gorlia

European Organisation for Research and Treatment of Cancer — Netherlands

Medicine · Health Sciences

64h-index55.7kcitations378works3.92yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(289), Brain Metastases and Treatment(103), Radiomics and Machine Learning in Medical Imaging(82), Epigenetics and DNA Methylation(50), Cancer Genomics and Diagnostics(39)

Publications375 total

Epigenetic evolution of isocitrate dehydrogenase-wildtype glioblastomas
Neuro-Oncology·2025
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial
The Lancet Oncology·2025Open Access
Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed Glioblastoma
JAMA Network Open·2025· 1 citedOpen Access
BIOM-09. PROGNOSTIC AND PREDICTIVE MARKERS FOR OUTCOME IN PATIENTS WITH IDHMT TUMORS TREATED IN THE EORTC CATNON TRIAL ON ADJUVANT AND/OR CONCURRENT TEMOZOLOMIDE IN ANAPLASTIC ASTROCYTOMA
Neuro-Oncology·2025· 1 citedOpen Access
INNV-04. Association of proton pump inhibitor use with outcome of patients with newly diagnosed glioblastoma
Neuro-Oncology·2025Open Access
CTNI-09. VORASIDENIB AS MAINTENANCE TREATMENT AFTER FIRST-LINE CHEMORADIOTHERAPY IN IDH-MUTANT GRADE 2/3 ASTROCYTOMA: STUDY PROTOCOL FOR THE PLACEBO-CONTROLLED, TRIPLE-BLIND, RANDOMIZED PHASE III STUDY EORTC-2427 (VIGOR)
Neuro-Oncology·2025Open Access
QOL-26. Health-Related Quality of Life in Molecular Glioma Subtypes: A Pooled Analysis from 16 Randomized Trials
Neuro-Oncology·2025Open Access
TIP-01. [177Lu]Lu-DOTATATE for recurrent meningioma (LUMEN-1, EORTC-2334-BTG): study protocol for a randomized phase II trial
Neuro-Oncology·2025· 1 citedOpen Access
QOL-22. Prognostic associations of the G8 geriatric screening tool in the EORTC Brain Tumor Group trials 1608 and 1709 in newly diagnosed glioblastoma
Neuro-Oncology·2025Open Access
Methodological aspects of economic evaluations and health economic models in glioblastoma: A systematic literature review
Neuro-Oncology Practice·2025Open Access
European NeuroOncology Quality Assessment (ENOQUA): A European Organization for the Research and Treatment of Cancer (EORTC) Brain Tumor Group Research Project
Neuro-Oncology Practice·2025
OS04.2.A FINAL CLINICAL AND MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1P/19Q CODELETION.
Neuro-Oncology·2025Open Access
OS01.7.A AGE AND SEX AS RISK FACTORS FOR HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN GLIOMA PATIENTS: POOLED ANALYSES OF CLINICAL TRIALS FROM THE CODAGLIO 2.0 DATABASE
Neuro-Oncology·2025Open Access
P17.15.A ASSOCIATION OF PROTON PUMP INHIBITOR USE WITH OUTCOME OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Neuro-Oncology·2025Open Access
P17.06.A VORASIDENIB AS MAINTENANCE TREATMENT AFTER FIRST-LINE CHEMORADIOTHERAPY IN IDH-MUTANT GRADE 2/3 ASTROCYTOMA: STUDY PROTOCOL FOR THE PLACEBO-CONTROLLED, TRIPLE-BLIND, RANDOMIZED PHASE III STUDY EORTC-2427 (VIGOR)
Neuro-Oncology·2025Open Access
3134eTiP EORTC GUCG 2418 STARBUST: “Strategies for treatment adaptation following re-evaluation of the bladder after using pRimary neoadjuvant systemic therapies”: An EORTC platform trial
Annals of Oncology·2025
667P Molecular landscape of tumors from long-term survivors with glioblastoma: Lessons from ETERNITY (EORTC 1419)
Annals of Oncology·2025
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling
Nature Cancer·2025· 5 cited
[ <sup>177</sup> Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II Trial
Journal of Nuclear Medicine·2025· 4 citedOpen Access
Prognostic value of 1D, 2D and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: radiological <i>post-hoc</i> analysis of the EORTC-BTG-1320 trial
Neuro-Oncology Advances·2025Open Access
page 1 of 19Next →

Frequent Co-authors

Martin J. van den Bent(36), Roger Stupp(22), Alba A. Brandes(20), Michael Weller(19), Johan M. Kros(18), Monika E. Hegi(16), Martin Taphoorn(13), Pim J. French(12), Wolfgang Wick(11), Vassilis Golfinopoulos(11), Warren Mason(10), Pieter Wesseling(9), Marc Sanson(9), Denis Lacombe(8), Olivier Chinot(8), Anouk Allgeier(7), Peter Hau(7), Denis Lacombe(7), Ahmed Idbaïh(7), Paul M. Clément(7)